PHASE-II TRIAL OF TRIGLYCIDYLURAZOL (TGU) IN ADVANCED MALIGNANT-MELANOMA

被引：0
|
作者：
GUNDERSEN, S
ABELE, R
CAVALLI, F
CLAVEL, M
DODION, P
RENARD, G
VANGLABBEKE, M
机构：
[1] HOP CANTONAL,CH-1205 GENEVA,SWITZERLAND
[2] OSPED SAN GIOVANNI,SERV ONCOL,CH-6500 BELLINZNA,SWITZERLAND
[3] CTR LEON BERARD,F-69373 LYON 2,FRANCE
[4] INST JULES BORDET,B-1000 BRUSSELS,BELGIUM
[5] EORTC DATA CTR,B-1000 BRUSSELS,BELGIUM
来源：
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1987年 / 23卷 / 02期
关键词：
D O I：
10.1016/0277-5379(87)90022-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：251 / 252
页数：2
相关论文
共 50 条
  • [21] PHASE-II TRIAL OF 4'-EPI-DOXORUBICIN IN PATIENTS WITH ADVANCED MALIGNANT-MELANOMA
    BERMAN, E
    CASPER, ES
    HOWARD, J
    WITTES, RE
    CANCER TREATMENT REPORTS, 1984, 68 (04): : 679 - 680
  • [22] MULTICENTER PHASE-II TRIAL OF THE SINGLE AGENT FOTEMUSTINE IN PATIENTS WITH ADVANCED MALIGNANT-MELANOMA
    CALABRESI, F
    AAPRO, M
    BECQUART, D
    DIRIX, L
    WILS, J
    ARDIZZONI, A
    GERARD, B
    ANNALS OF ONCOLOGY, 1991, 2 (05) : 377 - 378
  • [23] PHASE-II TRIAL OF MVE-II IN METASTIC MALIGNANT-MELANOMA
    RINEHART, J
    LAFORGE, J
    GOCHNOUR, D
    NEIDHART, J
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1987, 24 (03) : 244 - 246
  • [24] PHASE-II TRIAL OF FOTEMUSTINE IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA
    FALKSON, CI
    FALKSON, G
    FALKSON, HC
    INVESTIGATIONAL NEW DRUGS, 1994, 12 (03) : 251 - 254
  • [25] PHASE-II TRIAL OF LYMPHOBLASTOID INTERFERON IN METASTATIC MALIGNANT-MELANOMA
    GOLDBERG, RM
    AYOOB, M
    SILGALS, R
    AHLGREN, JD
    NEEFE, JR
    CANCER TREATMENT REPORTS, 1985, 69 (7-8): : 813 - 816
  • [26] PHASE-II STUDY OF META-AMSA IN ADVANCED MALIGNANT-MELANOMA
    ARSENEAU, JC
    WOLTER, JM
    PROBERT, JC
    KUPERMINC, M
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (04): : 433 - 436
  • [27] PHASE-II STUDY WITH ESORUBICIN (DXDX) IN ADVANCED MALIGNANT-MELANOMA (MMA)
    FRUSTACI, S
    GASPARINI, G
    GALLIGIONI, E
    TUMOLO, S
    FIGOLI, F
    MONFARDINI, S
    TUMORI JOURNAL, 1986, 72 (06): : 709 - 709
  • [28] POSITIVE PHASE-II STUDY IN THE TREATMENT OF ADVANCED MALIGNANT-MELANOMA WITH FOTEMUSTINE
    SCHALLREUTER, KU
    WENZEL, E
    BRASSOW, FW
    BERGER, J
    BREITBART, EW
    TEICHMANN, W
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1991, 29 (01) : 85 - 87
  • [29] PHASE-II TRIAL OF DOCETAXEL IN PATIENTS WITH ADVANCED CUTANEOUS MALIGNANT-MELANOMA PREVIOUSLY UNTREATED WITH CHEMOTHERAPY
    BEDIKIAN, AY
    WEISS, GR
    LEGHA, SS
    BURRIS, HA
    ECKARDT, JR
    JENKINS, J
    ETON, O
    BUZAID, AC
    SMETZER, L
    VONHOFF, DD
    BENJAMIN, RS
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (12) : 2895 - 2899
  • [30] RANDOMIZED PHASE-II TRIAL OF TCNU VERSUS MITOZOLOMIDE IN MALIGNANT-MELANOMA
    SMYTH, JF
    GUNDERSEN, S
    RENARD, J
    PINEDO, HM
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (04): : 755 - 757
12345